1. Home
  2. SPRB vs BOF Comparison

SPRB vs BOF Comparison

Compare SPRB & BOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRB
  • BOF
  • Stock Information
  • Founded
  • SPRB 2014
  • BOF 2017
  • Country
  • SPRB United States
  • BOF United States
  • Employees
  • SPRB N/A
  • BOF N/A
  • Industry
  • SPRB Medicinal Chemicals and Botanical Products
  • BOF Packaged Foods
  • Sector
  • SPRB Health Care
  • BOF Consumer Staples
  • Exchange
  • SPRB Nasdaq
  • BOF Nasdaq
  • Market Cap
  • SPRB 15.7M
  • BOF 15.1M
  • IPO Year
  • SPRB 2020
  • BOF 2023
  • Fundamental
  • Price
  • SPRB $0.42
  • BOF $1.91
  • Analyst Decision
  • SPRB Hold
  • BOF
  • Analyst Count
  • SPRB 7
  • BOF 0
  • Target Price
  • SPRB $2.17
  • BOF N/A
  • AVG Volume (30 Days)
  • SPRB 417.1K
  • BOF 140.5K
  • Earning Date
  • SPRB 03-12-2025
  • BOF 04-01-2025
  • Dividend Yield
  • SPRB N/A
  • BOF N/A
  • EPS Growth
  • SPRB N/A
  • BOF N/A
  • EPS
  • SPRB N/A
  • BOF N/A
  • Revenue
  • SPRB $7,101,000.00
  • BOF $6,489,951.00
  • Revenue This Year
  • SPRB N/A
  • BOF N/A
  • Revenue Next Year
  • SPRB N/A
  • BOF N/A
  • P/E Ratio
  • SPRB N/A
  • BOF N/A
  • Revenue Growth
  • SPRB N/A
  • BOF 372.36
  • 52 Week Low
  • SPRB $0.34
  • BOF $0.61
  • 52 Week High
  • SPRB $5.95
  • BOF $4.11
  • Technical
  • Relative Strength Index (RSI)
  • SPRB 58.94
  • BOF 39.91
  • Support Level
  • SPRB $0.38
  • BOF $2.40
  • Resistance Level
  • SPRB $0.42
  • BOF $2.59
  • Average True Range (ATR)
  • SPRB 0.03
  • BOF 0.20
  • MACD
  • SPRB 0.00
  • BOF -0.08
  • Stochastic Oscillator
  • SPRB 69.77
  • BOF 7.50

About SPRB Spruce Biosciences Inc.

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).

About BOF BranchOut Food Inc.

Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are primarily located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.

Share on Social Networks: